BPC-157 is the dominant component of the KLOW blend at 50mg 62.5% of total mass
The ATTAIN-2 trial extended the work to adults with both obesity and Type 2 diabetes, a group that often faces slower weight loss
All kinds of products we produce here are WHO , GMP , and ISO certified
Some people may experience mild side effects such as soreness, redness, swelling, or tenderness at the injection site
The first 46 weeks of a switch can be underwhelming you're at a low dose of a new drug, possibly experiencing mild GI symptoms, and the weight loss you achieved on your old drug may temporarily stall
It is always suggested to place these foods in dry and cool places so their nutrient content and freshness would be maintained